JIDAM
"An Official Journal of IDA - Madras
Branch" ©2022.
Background: The SARS COV-2 virus outbreak led to a pandemic last year
wreaking havoc all over the world. With the next wave waiting to strike
India, a steep increase in the incidence of Covid – 19 associated
Mucormycosis cases in recent times amongst the Indian population showing
a mortality rate of 30-70% has been noted. Most patients show signs and
symptoms pertaining to the oral cavity and peri-oral structures. Therefore, the
need for the dental fraternity to be aware about its clinical presentation and
pathophysiology plays a crucial role in early diagnosis of Mucorales
infection.
Material and Methods: A cross sectional study was conducted amongst
dental practitioners across India. 703 responders responded to a questionnaire
that consisted of 15 questions, which were divided into subheadings of
Knowledge, Attitude and Practices having 5 questions each.
Results: On statistical analysis of question-wise data received, out of a total
of 15 questions, majority of the questions showed highly statistical
significance between BDS and MDS responders.The questionnaire was
divided into three categories Knowledge, Attitude and Practices. The number
of responses were evaluated by a scoring system for each respondent and
compared for knowledge attitude and practices. The number of years into
practice and qualification were compared. Knowledge Attitude and a sum of
Knowledge, attitude and practices amongst BDS and MDS respondents
showed statistical significance (p>0.05) and with increase in number of years
into dental practice there was no statistical difference seen amongst the sub
groups.
Conclusion: The need for prompt, accurate and effective treatment in
today‘s trying times cannot be overlooked. This study primarily focuses on
critical and timely management of the deadly disease. However, knowledge
about current consensus, pathophysiology, occurrence and incidence can
further help the medical fraternity through the challenging times of this
epidemic and pandemic.
covid-19 associated mucormycosis, mucormycosis,
Volume No: 9, Issue No: 4